UCB SA (UCB.BR)

EUR 136.3

(-1.52%)

Eps Summary of UCB SA

  • UCB SA's latest annual eps in 2023 was 1.81 EUR , down -17.73% from previous year.
  • UCB SA's latest quarterly eps in 2024 Q2 was 1.10 EUR , down 0.0% from previous quarter.
  • UCB SA reported an annual eps of 2.20 EUR in 2022, down -60.71% from previous year.
  • UCB SA reported an annual eps of 5.60 EUR in 2021, up 44.7% from previous year.
  • UCB SA reported a quarterly eps of 1.64 EUR for 2023 Q2, down 0.0% from previous quarter.
  • UCB SA reported a quarterly eps of N/A for 2023 FY, down -17.73% from previous quarter.

Annual Eps Chart of UCB SA (2023 - 2002)

Historical Annual Eps of UCB SA (2023 - 2002)

Year Eps Eps Growth
2023 1.81 EUR -17.73%
2022 2.20 EUR -60.71%
2021 5.60 EUR 44.7%
2020 3.87 EUR -8.51%
2019 4.23 EUR -0.24%
2018 4.24 EUR 6.27%
2017 3.99 EUR 38.54%
2016 2.88 EUR 110.22%
2015 1.37 EUR 128.33%
2014 0.60 EUR 33.33%
2013 0.45 EUR -83.81%
2012 2.78 EUR 3.73%
2011 2.68 EUR 135.09%
2010 1.14 EUR -80.0%
2009 5.70 EUR 1087.5%
2008 0.48 EUR -73.03%
2007 1.78 EUR -64.96%
2006 5.08 EUR -51.71%
2005 10.52 EUR 131.72%
2004 4.54 EUR -1.94%
2003 4.63 EUR 25.47%
2002 3.69 EUR 0.0%

Peer Eps Comparison of UCB SA

Name Eps Eps Difference
Nicox S.A. -0.42 EUR 530.952%
European Medical Solutions -0.00 EUR 362100.0%
FERMENTALG -0.32 EUR 665.625%
argenx SE -4.67 EUR 138.758%
BioSenic S.A. -0.21 EUR 961.905%
Celyad Oncology SA -0.33 EUR 648.485%
Hyloris Pharmaceuticals SA -0.55 EUR 429.091%
Onward Medical N.V. -1.20 EUR 250.833%
Oxurion NV -0.01 EUR 15839.13%
PHAXIAM Therapeutics S.A. -5.00 EUR 136.2%
Financière de Tubize SA 1.98 EUR 8.586%